Geron Corporation

GERN09 Dec 2024
Healthcare
$3.94
-0.01 (-0.76%)
Lowest Today
$3.9
Highest Today
$4.08
Today’s Open
$3.94
Prev. Close
$3.93
52 Week High
$5.34
52 Week Low
$1.64
To Invest in Geron Corporation

Geron Corporation

Healthcare
GERN09 Dec 2024
-0.01 (-0.76%)
1M
3M
6M
1Y
5Y
Low
$3.9
Day’s Range
High
$4.08
3.9
52 Week Low
$1.64
52-Week Range
52 Week High
$5.34
1.64
1 Day
-
1 Week
-3.09%
1 month return
-7.89%
3 month return
-11.33%
6 month return
-22.34%
1 Year return
+89.8%
3 Years return
+171.52%
5 Years return
+155.55%
10 Years return
-
Institutional Holdings
BlackRock Inc
7.7
RTW INVESTMENTS, LLC
7.3
Vanguard Group Inc
5.37
RA Capital Management, LLC
5.34
State Street Corp
4.79
Adage Capital Partners Gp LLC
4.78
Vivo Capital, LLC
4.5

Market Status

Fundamentals
Market Cap
2375.69 mln
PB Ratio
8.23
PE Ratio
0
Enterprise Value
2153.4 mln
Total Assets
394.08 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Organisation
Geron Corporation
Employees
141
Industry
Biotechnology
CEO
Dr. John A. Scarlett M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step